作者:Tom Y.H. Wu、Hélène Juteau、Yves Ducharme、Richard W. Friesen、Sébastien Guiral、Lynn Dufresne、Hugo Poirier、Myriam Salem、Denis Riendeau、Joseph Mancini、Christine Brideau
DOI:10.1016/j.bmcl.2010.09.129
日期:2010.12
Microsomal prostaglandin E2 synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl imidazole scaffold exhibits excellent inhibition of PGE2 production in enzymatic and cell-based assays
微粒体前列腺素E 2合酶(mPGES-1)代表了新型镇痛药和抗炎药的潜在靶标。高通量筛选确定了mPGES-1抑制剂的几条线索,并对其效力和选择性进行了进一步优化。一系列带有联芳基咪唑支架的抑制剂在酶法和基于细胞的测定法中均表现出对PGE 2产生的优异抑制作用。将讨论这些分子的合成及其活性。